|
1
|
Hendrick AM, Gibson MV and Kulshreshtha A:
Diabetic retinopathy. Prim Care. 42:451–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang X, Bao S, Lai D, Rapkins RW and
Gillies MC: Intravitreal triamcinolone acetonide inhibits breakdown
of the blood-retinal barrier through differential regulation of
VEGF-A and its receptors in early diabetic rat retinas. Diabetes.
57:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Frank RN: Diabetic retinopathy. N Engl J
Med. 350:48–58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yau JW, Rogers SL, Kawasaki R, Lamoureux
EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund
J, et al: Meta-Analysis for Eye Disease (META-EYE) Study Group:
Global prevalence and major risk factors of diabetic retinopathy.
Diabetes Care. 35:556–564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheung CM, Vania M, Ang M, Chee SP and Li
J: Comparison of aqueous humor cytokine and chemokine levels in
diabetic patients with and without retinopathy. Mol Vis.
18:830–837. 2012.PubMed/NCBI
|
|
6
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Milne R and Brownstein S: Advanced
glycation end products and diabetic retinopathy. Amino Acids.
44:1397–1407. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu H, Cai M and Zhang X: Effect of the
blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced
diabetic retinopathy in rats. Graefes Arch Clin Exp Ophthalmol.
253:1485–1492. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Afzal N, Zaman S, Asghar A, Javed K,
Shahzad F, Zafar A and Nagi AH: Negative association of serum IL-6
and IL-17 with type-II diabetes retinopathy. Iran J Immunol.
11:40–48. 2014.PubMed/NCBI
|
|
10
|
Takeuchi M, Sato T, Tanaka A, Muraoka T,
Taguchi M, Sakurai Y, Karasawa Y and Ito M: Elevated levels of
cytokins associated with Th2 and Th17 cells in vitreous fluid of
proliferative diabetic retinopathy patients. PLoS One.
10:e01373582015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nadeem A, Javaid K, Sami W, Zafar A, Jahan
S, Zaman S and Nagi A: Inverse relationship of serum IL-17 with
type-II diabetes retinopathy. Clin Lab. 59:1311–1317.
2013.PubMed/NCBI
|
|
12
|
Afzal N, Zaman S, Shahzad F, Javaid K,
Zafar A and Nagi AH: Immune mechanisms in type-2 diabetic
retinopathy. J Pak Med Assoc. 65:159–163. 2015.PubMed/NCBI
|
|
13
|
Longo VD and Kennedy BK: Sirtuins in aging
and age-related disease. Cell. 126:257–268. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li T, Zhang J, Feng J, Li Q, Wu L, Ye Q,
Sun J, Lin Y, Zhang M, Huang R, et al: Resveratrol reduces acute
lung injury in a LPS-induced sepsis mouse model via activation of
Sirt1. Mol Med Rep. 7:1889–1895. 2013.PubMed/NCBI
|
|
15
|
Sung B, Chung JW, Bae HR, Choi JS, Kim CM
and Kim ND: Humulus japonicus extract exhibits antioxidative
and anti-aging effects via modulation of the AMPK-SIRT1 pathway.
Exp Ther Med. 9:1819–1826. 2015.PubMed/NCBI
|
|
16
|
Balaiya S, Khetpal V and Chalam KV:
Hypoxia initiates sirtuin1-mediated vascular endothelial growth
factor activation in choroidal endothelial cells through hypoxia
inducible factor-2α. Mol Vis. 18:114–120. 2012.PubMed/NCBI
|
|
17
|
Zheng Z, Chen H, Li J, Li T, Zheng B,
Zheng Y, Jin H, He Y, Gu Q and Xu X: Sirtuin 1-mediated cellular
metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and
therapeutic effects of metformin. Diabetes. 61:217–228. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gardner PJ, Joshi L, Lee RW, Dick AD,
Adamson P and Calder VL: SIRT1 activation protects against
autoimmune T cell-driven retinal disease in mice via inhibition of
IL-2/Stat5 signaling. J Autoimmun. 42:117–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park YD, Kim YS, Jung YM, Lee SI, Lee YM,
Bang JB and Kim EC: Porphyromonas gingivalis
lipopolysaccharide regulates interleukin (IL)-17 and IL-23
expression via SIRT1 modulation in human periodontal ligament
cells. Cytokine. 60:284–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: Diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabetic Med.
15:539–553. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Der Pathologe. 8:138–140. 1987.(In German).
PubMed/NCBI
|
|
22
|
Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y
and Yang P: Decreased interleukin 27 expression is associated with
active uveitis in Behçet's disease. Arthritis Res Ther.
16:R1172014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Howitz KT, Bitterman KJ, Cohen HY, Lamming
DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL,
et al: Small molecule activators of sirtuins extend
Saccharomyces cerevisiae lifespan. Nature. 425:191–196.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sumarac-Dumanovic M, Jeremic D, Pantovic
A, Janjetovic K, Stamenkovic-Pejkovic D, Cvijovic G, Stevanovic D,
Micic D and Trajkovic V: Therapeutic improvement of glucoregulation
in newly diagnosed type 2 diabetes patients is associated with a
reduction of IL-17 levels. Immunobiology. 218:1113–1118. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zizzo G, De Santis M, Bosello SL, Fedele
AL, Peluso G, Gremese E, Tolusso B and Ferraccioli G: Synovial
fluid-derived T helper 17 cells correlate with inflammatory
activity in arthritis, irrespectively of diagnosis. Clin Immunol.
138:107–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lynde CW, Poulin Y, Vender R, Bourcier M
and Khalil S: Interleukin 17A: Toward a new understanding of
psoriasis pathogenesis. J Am Acad Dermatol. 71:141–150. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Esendagli G, Kurne AT, Sayat G, Kilic AK,
Guc D and Karabudak R: Evaluation of Th17-related cytokines and
receptors in multiple sclerosis patients under interferon β-1
therapy. J Neuroimmunol. 255:81–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wong CK, Lit LC, Tam LS, Li EK, Wong PT
and Lam CW: Hyperproduction of IL-23 and IL-17 in patients with
systemic lupus erythematosus: Implications for Th17-mediated
inflammation in auto-immunity. Clin Immunol. 127:385–393. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Numasaki M, Fukushi J, Ono M, Narula SK,
Zavodny PJ, Kudo T, Robbins PD, Tahara H and Lotze MT:
Interleukin-17 promotes angiogenesis and tumor growth. Blood.
101:2620–2627. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suryawanshi A, Veiga-Parga T, Reddy PB,
Rajasagi NK and Rouse BT: IL-17A differentially regulates corneal
vascular endothelial growth factor (VEGF)-A and soluble VEGF
receptor 1 expression and promotes corneal angiogenesis after
herpes simplex virus infection. J Immunol. 188:3434–3446. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Yang P, Li F and Kijlstra A: The
effects of Th17 cytokines on the inflammatory mediator production
and barrier function of ARPE-19 cells. PLoS One. 6:e181392011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee SI, Min KS, Bae WJ, Lee YM, Lee SY,
Lee ES and Kim EC: Role of SIRT1 in heat stress- and
lipopolysaccharide-induced immune and defense gene expression in
human dental pulp cells. J Endod. 37:1525–1530. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim YS, Lee YM, Park JS, Lee SK and Kim
EC: SIRT1 modulates high-mobility group box 1-induced
osteoclastogenic cytokines in human periodontal ligament cells. J
Cell Biochem. 111:1310–1320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Beier UH, Wang L, Bhatti TR, Liu Y, Han R,
Ge G and Hancock WW: Sirtuin-1 targeting promotes Foxp3+
T-regulatory cell function and prolongs allograft survival. Mol
Cell Biol. 31:1022–1029. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maloney SC, Antecka E, Granner T,
Fernandes B, Lim LA, Orellana ME and Burnier MN Jr: Expression of
SIRT1 in choroidal neovascular membranes. Retina. 33:862–866. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pacholec M, Bleasdale JE, Chrunyk B,
Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis
P and Pabst B: SRT1720, SRT2183, SRT1460, and resveratrol are not
direct activators of SIRT1. J Biol Chem. 285:8340–8351. 2010.
View Article : Google Scholar : PubMed/NCBI
|
